• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Portfolio

/ November 14, 2016

AEB Group

AEB

AEB Group is a global leader in providing an integrated suite of products and related services – including a full spectrum of biotechnology solutions, processing aids and specialized equipment – for winemakers, beer brewers and other food and beverage producers. Headquartered in Brescia, Italy, AEB Group operates a network of eight production facilities and eight proprietary laboratories throughout Europe and the Americas.

SK Capital acquired a controlling interest in AEB Group in April 2015.

In October 2018, AEB Group was sold to Apax Partners.

For more information, please visit: www.aeb-group.com

Primary Sidebar

Related News

  • Apax Partners to acquire AEB Group from SK Capital

    September 28, 2018
  • AEB Group Completes Acquisition of Innotec

    August 8, 2017
  • SK Capital Closes Control Investment In AEB Group

    April 30, 2015
  • SK Capital Announces Control Investment In AEB Group

    March 19, 2015

SK Capital Portfolio Companies

  • Luxium Solutions
  • VanDeMark Chemical, Inc
  • Valtris Specialty Chemicals
  • Florachem
  • Heubach
  • Seqens
  • Deltech LLC
  • Canlak
  • IPACKCHEM
  • Woodstock Sterile Solutions
  • Lacerta Group
  • Venator
  • Tilley Distribution
  • NuCera Solutions
  • Techmer PM
  • GEON
  • SI Group
  • Perimeter Solutions
  • Wavelength
  • Foremark
  • Tri-Tex
  • Niacet
  • Noramco
  • Extractas Bioscience
  • Purisys
  • Archroma
  • Addivant
  • TPC Group
  • Ascend
  • IBA Molecular
  • Calabrian Corporation
  • Halo Pharmaceutical
  • AEB Group

To request for a copy of our ESG report, please click here.

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login